Stock Quote
Acorda News & Events
SEE THE LATEST PRESS RELEASES
| Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage Strengths |
| More |
Sign up for
e-mail updates
STAY IN TOUCH
WITH ACORDA
Sign up for e-mail updates.
CORPORATE PROFILE
Acorda Therapeutics, Inc. is a biotechnology company whose mission is to develop and market... Learn more
UPCOMING EVENTS
Acorda participate in medical, financial and advocacy events throughout the year. See what’s next on Acorda’s calendar. More
Featured Video
Maria's Story
"Honest, meaningful and impactful communication is what people can expect from us."
